• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

微生物病原体对囊性纤维化和慢性阻塞性肺疾病患者气道的差异适应。

Differential adaptation of microbial pathogens to airways of patients with cystic fibrosis and chronic obstructive pulmonary disease.

机构信息

Institute of Medical Microbiology and Hygiene, Universitätsklinikum Tübingen, Tübingen, Germany.

出版信息

FEMS Microbiol Rev. 2011 Jan;35(1):124-46. doi: 10.1111/j.1574-6976.2010.00237.x.

DOI:10.1111/j.1574-6976.2010.00237.x
PMID:20584083
Abstract

Cystic fibrosis (CF), the most common autosomal recessive disorder in Caucasians, and chronic obstructive pulmonary disease (COPD), a disease of adults, are characterized by chronic lung inflammation, airflow obstruction and extensive tissue remodelling, which have a major impact on patients' morbidity and mortality. Airway inflammation is stimulated in CF by chronic bacterial infections and in COPD by environmental stimuli, particularly from smoking. Pseudomonas aeruginosa is the major bacterial pathogen in CF, while in COPD, Haemophilus influenzae is most frequently observed. Molecular studies indicate that during chronic pulmonary infection, P. aeruginosa clones genotypically and phenotypically adapt to the CF niche, resulting in a highly diverse bacterial community that is difficult to eradicate therapeutically. Pseudomonas aeruginosa clones from COPD patients remain within the airways only for limited time periods, do not adapt and are easily eradicated. However, in a subgroup of severely ill COPD patients, P. aeruginosa clones similar to those in CF persist. In this review, we will discuss the pathophysiology of lung disease in CF and COPD, the complex genotypic and phenotypic adaptation processes of the opportunistic bacterial pathogens and novel treatment options.

摘要

囊性纤维化 (CF) 是白种人中最常见的常染色体隐性遗传病,慢性阻塞性肺疾病 (COPD) 是一种成人疾病,其特征为慢性肺炎症、气流阻塞和广泛的组织重塑,这对患者的发病率和死亡率有重大影响。CF 中的气道炎症是由慢性细菌感染引起的,COPD 中的气道炎症是由环境刺激物引起的,特别是吸烟。铜绿假单胞菌是 CF 的主要细菌病原体,而流感嗜血杆菌在 COPD 中最常见。分子研究表明,在慢性肺部感染过程中,铜绿假单胞菌克隆在基因和表型上适应 CF 生态位,导致形成高度多样化的细菌群落,难以进行治疗性根除。COPD 患者的铜绿假单胞菌克隆仅在气道中存在有限的时间,不会适应,并且容易被根除。然而,在一组患有严重 COPD 的患者中,与 CF 中相似的铜绿假单胞菌克隆持续存在。在这篇综述中,我们将讨论 CF 和 COPD 中肺部疾病的病理生理学,机会性细菌病原体的复杂基因和表型适应过程,以及新的治疗选择。

相似文献

1
Differential adaptation of microbial pathogens to airways of patients with cystic fibrosis and chronic obstructive pulmonary disease.微生物病原体对囊性纤维化和慢性阻塞性肺疾病患者气道的差异适应。
FEMS Microbiol Rev. 2011 Jan;35(1):124-46. doi: 10.1111/j.1574-6976.2010.00237.x.
2
Bacterial sinusitis can be a focus for initial lung colonisation and chronic lung infection in patients with cystic fibrosis.细菌性鼻窦炎可成为囊性纤维化患者肺部初始定植和慢性肺部感染的病灶。
J Cyst Fibros. 2013 Sep;12 Suppl 2:S1-20. doi: 10.1016/S1569-1993(13)00150-1.
3
Emergence and persistence of Pseudomonas aeruginosa in the cystic fibrosis airway.铜绿假单胞菌在囊性纤维化气道中的出现与持续存在。
Semin Respir Infect. 1992 Sep;7(3):168-78.
4
Breathing pattern and chest wall volumes during exercise in patients with cystic fibrosis, pulmonary fibrosis and COPD before and after lung transplantation.肺移植前后囊性纤维化、肺纤维化和 COPD 患者运动时的呼吸模式和胸壁容量。
Thorax. 2010 Sep;65(9):808-14. doi: 10.1136/thx.2009.131409.
5
Challenging and emerging pathogens in cystic fibrosis.囊性纤维化中的挑战性和新兴病原体。
Paediatr Respir Rev. 2010 Dec;11(4):246-54. doi: 10.1016/j.prrv.2010.07.003. Epub 2010 Aug 7.
6
Clonal epidemiology of Pseudomonas aeruginosa in cystic fibrosis.铜绿假单胞菌在囊性纤维化中的克隆流行病学。
Int J Med Microbiol. 2010 Dec;300(8):526-33. doi: 10.1016/j.ijmm.2010.08.004. Epub 2010 Oct 14.
7
Lung infection with alginate-producing, mucoid Pseudomonas aeruginosa in cystic fibrosis.囊性纤维化患者肺部感染产藻酸盐的黏液型铜绿假单胞菌。
APMIS Suppl. 1992;28:1-79.
8
[A clinical study of bacterial infection in patients with chronic obstructive pulmonary disease].[慢性阻塞性肺疾病患者细菌感染的临床研究]
Zhonghua Jie He He Hu Xi Za Zhi. 1999 Feb;22(2):88-91.
9
Cystic fibrosis: infection.囊性纤维化:感染
Schweiz Med Wochenschr. 1991 Jan 26;121(4):105-9.
10
Respiratory bacterial infections in cystic fibrosis.囊性纤维化中的呼吸细菌感染。
Curr Opin Pulm Med. 2013 May;19(3):251-8. doi: 10.1097/MCP.0b013e32835f1afc.

引用本文的文献

1
Polymicrobial Biofilms: Interkingdom Interactions, Resistance and Therapeutic Strategies.多微生物生物膜:跨界相互作用、耐药性及治疗策略
Microb Biotechnol. 2025 Aug;18(8):e70218. doi: 10.1111/1751-7915.70218.
2
Biofilm Formation of in Cystic Fibrosis: Mechanisms of Persistence, Adaptation, and Pathogenesis.囊性纤维化中生物膜的形成:持续存在、适应及发病机制
Microorganisms. 2025 Jun 30;13(7):1527. doi: 10.3390/microorganisms13071527.
3
Corticosteroids modulate biofilm formation and virulence of .皮质类固醇调节……的生物膜形成和毒力。 (原文此处不完整)
Biofilm. 2025 May 29;9:100289. doi: 10.1016/j.bioflm.2025.100289. eCollection 2025 Jun.
4
in chronic lung disease: untangling the dysregulated host immune response.在慢性肺部疾病中:理清失调的宿主免疫反应。
Front Immunol. 2024 Jun 28;15:1405376. doi: 10.3389/fimmu.2024.1405376. eCollection 2024.
5
An Overview of Biofilm-Associated Infections and the Role of Phytochemicals and Nanomaterials in Their Control and Prevention.生物膜相关感染概述以及植物化学物质和纳米材料在其控制与预防中的作用
Pharmaceutics. 2024 Jan 24;16(2):162. doi: 10.3390/pharmaceutics16020162.
6
Responses of carbapenemase-producing and non-producing carbapenem-resistant strains to meropenem revealed by quantitative tandem mass spectrometry proteomics.通过定量串联质谱蛋白质组学揭示产碳青霉烯酶和不产碳青霉烯酶的耐碳青霉烯菌株对美罗培南的反应。
Front Microbiol. 2023 Feb 9;13:1089140. doi: 10.3389/fmicb.2022.1089140. eCollection 2022.
7
Kaempferol: Antimicrobial Properties, Sources, Clinical, and Traditional Applications.山奈酚:抗菌特性、来源、临床应用和传统应用。
Int J Mol Sci. 2022 Nov 30;23(23):15054. doi: 10.3390/ijms232315054.
8
Whole Genome Multi-Locus Sequence Typing and Genomic Single Nucleotide Polymorphism Analysis for Epidemiological Typing of From Indonesian Intensive Care Units.用于印度尼西亚重症监护病房流行病学分型的全基因组多位点序列分型和基因组单核苷酸多态性分析
Front Microbiol. 2022 Jul 14;13:861222. doi: 10.3389/fmicb.2022.861222. eCollection 2022.
9
Airway is Associated with Poor Response to Immunotherapy in Lung Cancer.气道与肺癌免疫治疗反应不佳相关。
Onco Targets Ther. 2022 Feb 28;15:201-213. doi: 10.2147/OTT.S348382. eCollection 2022.
10
Lung microbiome of stable and exacerbated COPD patients in Tshwane, South Africa.南非茨瓦内稳定期和加重期 COPD 患者的肺部微生物组。
Sci Rep. 2021 Oct 5;11(1):19758. doi: 10.1038/s41598-021-99127-w.